Abstract

PurposeCatheter ablation for atrial fibrillation (AF) is a standard procedure for maintaining sinus rhythm. The aim of this study was to evaluate treatment success and its predictors and to provide quality control data on complications and redo operations in a centre with an initially a low but currently high annual volume.MethodsData on patients (n = 1,253) treated with catheter ablation for AF in Tays Heart Hospital between January 2010 and May 2018 was evaluated (n = 1178 ablation-naïve patients and n = 1514 AF ablations). Comprehensive data on patient characteristics, treatment results, redo operations and complications were collected. Treatment success (maintenance of sinus rhythm at 1 year) was evaluated among patients residing within the hospital district (45% of the entire study population).ResultsTreatment success was observed in approximately 62.9% of the ablation-naïve patients. Preoperative predictors of treatment success were paroxysmal AF type, previous use of antiarrhythmic drugs, left atrium diameter and age. The experience at the centre did not associate with the 1-year outcome. A relapse during the first 3-month blanking period was associated with a nine-fold risk of failure at 1 year (unadjusted OR 9.1, 95% CI 5.5–15.1, p < 0.001). The major complication rate was 4.5% (68/1514) with no deaths. Ten percent of the patients needed a redo procedure within the first year.ConclusionsPatient-related factors are the most significant predictors of treatment success. A relapse during a 3-month blanking period is associated with a very high risk of failure at 1 year.

Highlights

  • Catheter ablation for atrial fibrillation (AF), to antiarrhythmic drug (AAD) therapy, is generally an effective and relatively safe therapy aimed at restoring and maintaining sinus rhythm (SR) and, subsequently, improving the quality of life [1,2,3]

  • This is a retrospective registry study on patients treated with catheter ablation for AF by means of pulmonary vein isolation (PVI) between 1 January 2010 and 15 May 2018 in Tays Heart Hospital

  • The majority of the procedures were performed on patients with paroxysmal atrial fibrillation (62.9%, n = 749)

Read more

Summary

Introduction

Catheter ablation for atrial fibrillation (AF), to antiarrhythmic drug (AAD) therapy, is generally an effective and relatively safe therapy aimed at restoring and maintaining sinus rhythm (SR) and, subsequently, improving the quality of life [1,2,3]. There have been attempts to generate prediction models for AF recurrence after ablation, such as the APPLE score [13,14,15] The purpose of this retrospective study was to examine the performance of a large centre performing catheter ablations for atrial fibrillation and to evaluate the prognostic value of several clinical variables as regards treatment success. This data adds to the cost-efficiency analysis of catheter

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call